This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2024
AMA 2024
ASCO 2024
AUA 2024
APCCC 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO 2023
ASCO 2023 Prostate Cancer
ASCO 2023
Prostate Cancer
Testicular and Penile Cancer
Press Releases
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Carcinoma
ASCO 2023 Prostate Cancer
Viewing 181-200 of 11487 articles
ASCO 2024: Molecular Imaging for Prostate Cancer: When and Which Agents.
ASCO 2024: Responsible and Equitable Biomarker Stewardship: How Do We Ensure Access to All Patients
ASCO 2024: Practical Approach to Genetic Testing and Treatment Selection in Prostate Cancer.
ASCO 2024: Bladder-Sparing Treatment Strategies for Localized Urothelial Cancer
Blue Earth Diagnostics Highlights Presentations on POSLUMA® (Flotufolastat F 18), Axumin® (Fluciclovine F 18) and Investigational 18F-Flotufolastat/18F-rhPSMA-7 at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
AUA 2024: Key Takeaways for Sexual Dysfunction
CG Oncology to Present Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembro in BCG-Unresponsive High-Risk NMIBC
Bayer Presents Latest Data from Oncology Portfolio at 2024 ASCO Annual Meeting
AUA 2024: Long-term Dementia Risk with Use of Anticholinergic versus Beta-3-Agonist Pharmacotherapy for Overactive Bladder
AUA 2024: EvoPAR-Prostate01: Phase III, Double-Blind, Placebo-Controlled, 2-Cohort, Randomized Study of Saruparib (AZD5305) in Combination with New Hormonal Agents in Patients with mCSPC +/- HRR Mutations
AUA 2024: State-of-the-Art Lecture: Lasers in Endourology
AUA 2024: Back to Medical School: Immunology in NMIBC and Neoadjuvant MIBC for the Urologist
AUA 2024: State-of-the-Art Lecture: The UTI Vaccine
AUA 2024: Second Opinion Cases: Unable to Access Tight Ureter and UPJ Obstruction
AUA 2024: Evaluating AI Assistance in Prostate bpMRI Interpretation: A Multi-Reader Study
AUA 2024: State of the Art: Endocrinological Factors in the Etiology of Stone Disease
AUA 2024: Panel Discussion: Tricks and Tips of Penile Prosthesis Surgery
AUA 2024: Paradigm-Shifting, Practice-changing Clinical Trials in Urology: Office-Based Removal of Small Urinary Stones
AUA 2024: A Randomized Control Trial Assessing Renal Damage Caused by New High Power Lasers During Ureteroscopic Laser Lithotripsy
AUA 2024: Panel Discussion: Interstitial Cystitis/ Systemic Therapy for Bladder Pain Syndrome: Which Patient and Which Therapy?
5
6
7
8
9
10
11
12
13
14
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
